News | December 30, 2022
The company has plans to launch this Vaccine by the end of 2023 after completing the required field studies and obtaining regulatory approvals
The vectored intranasal delivery platform gives us the capability for rapid product development, scale-up, easy and painless immunization during public health emergencies and pandemics
Mock drills are being conducted across the country to review the preparedness for management of COVID-19
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
Miravo to remain a Canadian controlled and operated company following closing of the transaction
The organisation is also working towards providing skills based training programmes to the workers for paramedical jobs and has launched certificate courses in ten disciplines
Centre and states need to work in tandem and in a collaborative spirit as was done during the previous surges for COVID-19 prevention and management
The expansion in Indore is well-aligned with Lupin Diagnostics’ commitment to improving access to high-quality, reliable, and advanced testing centres and home collection facilities at an affordable price
Subscribe To Our Newsletter & Stay Updated
